Document Detail


Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants.
MedLine Citation:
PMID:  20819895     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Bordetella pertussis is a common, underrecognized, and vaccine-preventable cause of critical illness with a high mortality in infants worldwide. Patients with severe cases present with extreme leukocytosis and develop refractory hypoxemia and pulmonary hypertension that is unresponsive to maximal intensive care. This may reflect a hyperviscosity syndrome from the raised white blood cell (WBC) count. Case reports suggest improved outcomes with exchange transfusion to reduce the WBC count. Our objective was to quantify possible benefits of aggressive leukodepletion.
METHODS: We, as a regional PICU and extracorporeal membrane oxygenation referral center, adopted a strategy of aggressive leukodepletion in January 2005. The impact of this strategy on crude and case mix-adjusted survival of all infants who were critically ill with B pertussis were compared with control subjects from January 2001 to December 2004 and Extracorporeal Life Support Organisation registry data.
RESULTS: Nineteen infants (7 [37%] boys) received intensive care for B pertussis from 2001 to 2009. Admission WBC counts were equivalent in 2 time periods: 2001-2004 (mean: 52,000/μL) and 2005-2009 (mean: 75,000/μL). In 2001-2004, 5 (55%) of 9 patients survived the ICU. Between 2005 and 2009, 9 (90%) of 10 patients survived. When case-mix adjustment for age, WBC count, and extracorporeal membrane oxygenation referral were considered, the 2001-2004 predicted survival (4.4 [49%] of 9.0) was equivalent to the observed mortality (4.0 [44%] of 9.0). Between 2005 and 2009, observed mortality (1.0 [10%] of 10.0) was significantly better than predicted (4.7 [47%] of 10.0).
CONCLUSIONS: Leukodepletion should be considered in critically ill infants with B pertussis and leukocytosis.
Authors:
Helen E Rowlands; Allan P Goldman; Karen Harrington; Ann Karimova; Joe Brierley; Nigel Cross; Sophie Skellett; Mark J Peters
Related Documents :
11685305 - Pulmonary oxygen consumption: a hypothesis to explain the increase in oxygen consumptio...
16474255 - Early dynamic changes in pulse oximetry signals in preterm newborns with histologic cho...
3963865 - Incidence and mechanism of bradycardia during apnoea in preterm infants.
11531715 - New trends in extracorporeal membrane oxygenation in newborn pulmonary diseases.
17162495 - Risk of selected birth defects with prenatal illicit drug use, hawaii, 1986-2002.
16221885 - Uxt is a novel centrosomal protein essential for cell viability.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-06
Journal Detail:
Title:  Pediatrics     Volume:  126     ISSN:  1098-4275     ISO Abbreviation:  Pediatrics     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-05     Completed Date:  2010-10-27     Revised Date:  2011-01-03    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e816-27     Citation Subset:  AIM; IM    
Affiliation:
Cardiac Critical Care Unit, Great Ormond Street Hospital for Children NHS Trust, and Critical Care Group, Portex Unit, Institute of Child Health, University College London, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Critical Illness
Extracorporeal Membrane Oxygenation
Female
Humans
Infant
Intensive Care Units, Pediatric
Leukocyte Reduction Procedures*
Leukocytosis / complications,  therapy
Male
Risk Factors
Whooping Cough / blood,  mortality,  therapy*
Grant Support
ID/Acronym/Agency:
//Department of Health
Comments/Corrections
Comment In:
Expert Rev Vaccines. 2011 Jan;10(1):49-53   [PMID:  21162620 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spirometry Use Among Pediatric Primary Care Physicians.
Next Document:  Bisphenol A and Related Compounds in Dental Materials.